Core Laboratories (CLB) Share-based Compensation (2022 - 2026)

Core Laboratories has reported Share-based Compensation for 5 years, with the latest figure at $5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 20.99% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (up 158.89% YoY), and the FY2025 full-year result was $7.1 million, up 90.07% from the prior year.
• Share-based Compensation for Q1 2026 stood at $5.0 million, up from $1.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $9.0 million in Q1 2023, with the low at -$475000.0 in Q3 2024.
• Historically, Share-based Compensation has averaged $2.2 million across 5 years, with a median of $1.4 million in 2023.
• Annual changes were most pronounced in 2024 — Share-based Compensation slumped 129.27% — and 2025, when it surged 507.58%.
• Core Laboratories' Share-based Compensation stood at $304000.0 in 2022, then jumped by 414.8% to $1.6 million in 2023, then tumbled by 129.27% to -$458000.0 in 2024, then jumped by 343.23% to $1.1 million in 2025, then jumped by 351.71% to $5.0 million in 2026.
• The last three Share-based Compensation figures came in at $5.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.